Cite
HARVARD Citation
Clamp, A. et al. (2022). Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal cancer treatment (ICON8): overall survival results from an open-label, randomised, controlled, phase 3 trial. Lancet oncology. 23 (7), pp. 919-930. [Online].